To support rapidly expanding global peptides market
Lupin Manufacturing Solutions (LMS), a subsidiary of Lupin, today announced a long-term strategic alliance with PolyPeptide Group AG (PolyPeptide) (SIX: PPGN), a specialized, global CDMO for peptide-based active pharmaceutical ingredients. This collaboration aims to enhance supply chain resilience, improve operational efficiency, and accelerate readiness for the rapidly expanding global peptides market. It also advances next-generation peptide therapeutics, including those for metabolics, supporting the long-term strategic growth of both organizations.
As part of the alliance, both companies will work towards the following: h
Expanding sourcing options and fortifying peptide supply chains to meet rising global demand for peptide APIs, including for metabolic disease therapies. h Integrating procurement and supply planning h Ensuring unwavering quality and reliability and delivering superior service globallyThis partnership strengthens LMS as a leading CDMO supplier of peptide materials for both innovator and generic markets, while enhancing PolyPeptides position as a trusted CDMO partner.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
